The landscape of dementia prognosis has evolved drastically with the advent of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-based checks that will detect Alzheimer's pathology a long time prior to signs and symptoms arise. Even though these technological developments signify extraordinary development in knowing neurodegenerative diseases, https://carsonh319gqz8.ja-blog.com/profile